Insider trade

CEO sold ~$7.32M of ROIV shares in the open market

Traded Sep 30, 2026 · Filed Oct 3, 2026

Roivant SciencesROIV

~$7.32M
Reported value · 200K sh @ $36.62: 1.6M
Holds after · shares reported: −2.2%
stock since the trade · S&P 500 +1.6%, $36.57 → $35.78 on Oct 5

Why it stands out

The boss of Roivant Sciences sold $7.32M of Roivant Sciences shares. It was planned long ago, so it says very little.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 30, 2026
Reporting period: Not applicable
Filed with the SEC: Oct 3, 2026

CEO$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$7,324,000

Shares × reported transaction price

Timing vs results

55 days after results of Aug 6, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $36.57 on Sep 30, 2026, 128% above its 52-week low and 13% below its high, after a 2% drop over the previous 30 trading days

52-week range $16.03 (Oct 8, 2025) to $41.81 (Sep 9, 2026), 80% of the way up, from 248 adjusted closes. 30 trading days earlier: $37.37 on Aug 18, 2026. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references a pre-arranged trading plan (Rule 10b5-1)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001635088-26-000108
Filed / recorded: Oct 3, 2026, 1:37 AM UTC
Added to OQRO: Oct 6, 2026, 8:46 PM UTC
Parser: form4-xml-v2
Data quality: Verified: identifiers matched exactly
Issuer: Roivant Sciences Ltd.
Issuer CIK: 1635088
Ticker: ROIV
Reporting person: Eric Venker
Relationship: Officer
Officer title: President & Immunovant CEO
Security: Common Shares
Table: Non-derivative (Table I)
Transaction date: Sep 30, 2026
Transaction code: S
Shares / units: 200,000
Price per share: $36.62
Acquired / disposed: Disposed (D)
Shares owned after: 1,599,154
Ownership form: Direct
Amendment: No

Footnotes from the filing

The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.49 to $36.76, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Shares sold at each separate price within the range. These sales were effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted on March 28, 2025.

Around the same time

18KShares · @ $4.46

yesterday

Derivative exercise or conversion — not an open-market buy.

More Official record

Director sold ~$608K of Roivant Sciences

Scheduled in advanceyesterday

Director sold ~$33K of Roivant Sciences

Scheduled in advanceyesterday